The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients: A systematic review and meta-analysis

BACKGROUND: At present, there are a lot of research about the effect of Alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention (PCI) in diabetic patients, but the clinical efficacy is not consistent, so we conduct this study and therefore determine the dominant...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Ziliang, Lu, Haili, Guo, Wenqin, Dai, Weiran, Li, Hongqing, Yang, Huafeng, Li, Lang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120914/
https://www.ncbi.nlm.nih.gov/pubmed/27861357
http://dx.doi.org/10.1097/MD.0000000000005306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120914/
https://www.ncbi.nlm.nih.gov/pubmed/27861357
http://dx.doi.org/10.1097/MD.0000000000005306

Ejemplares similares